ISRCTN17418767已完成不适用
Immune response of fractional doses of Inactivated Poliovirus Vaccine (IPV) administered intradermally in the Sultanate of Oma
World Health Organization (WHO) (Switzerland)0 个研究点目标入组 400 人开始时间: 2007年8月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Healthy Omani newborns (greater than 2.5 kg, apgar score greater than 9 at five minutes)
- •2. Living within the catchment area of the participating study site
- •3. Newborns delivered by caesarean section
排除标准
- •1. Newborns requiring hospitalisation (except if in hospital because of maternal admission)
- •2. Birth weight below 2.5 kg
- •3. Apgar score less than 9 at five minutes
- •4. Non-Omani
- •5. Residence outside the catchment area, or families expecting to move away during the study period
- •6. A diagnosis or suspicion of immunodeficiency disorder (either in the participant or in a member of the immediate family) will also render the newborn ineligible for the study
研究者
相似试验
已完成
4 期
Comparison of immune response of fractional doses, administered intradermally vs. full doses administered intramuscularly of inactivated poliovirus vaccine (IPV) in male adults in Camaguey, Cuba.PoliomyelitisInfection - Other infectious diseasesPublic Health - EpidemiologyACTRN12615000305527World Health Organization600
进行中（未招募）
不适用
Trial to assess whether it is safe and efficient to vaccinate children with lower dose of Inactivated Poliovirus Vaccine (IPV) , Cuba 2017polioACTRN12617001525370WHO400
进行中（未招募）
不适用
Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses IntramuscularlyPoliomyelitisEUCTR2015-005183-42-Outside-EU/EEASanofi Pasteur SA236
已完成
不适用
Immune response of fractional doses of Inactivated Poliovirus Vaccine (IPV) administered intradermally in CubaPoliomyelitis vaccinationInfections and InfestationsPoliomyelitisISRCTN19673867World Health Organization (WHO) (Switzerland)320
尚未招募
3 期
Safety & Immunogenicity of Fractional Doses of Vaccines Among Nigerian Adults- A Randomised Non-Inferiority Triple Blind TrialCOVID -19PACTR202206754734018igeria Federal Ministry of health1,812